Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression

Clinical and Experimental Allergy

Volumn 28, Issue 7, 1998, Pages 808-816

  Van Neerven, R J J ^a,c   Van De Pol, M M ^a   Van Der Zee, J S ^a   Stiekema, F E M ^a   De Boer, M ^b   Kapsenberg, M L ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b PanGenetics BV   (Netherlands)

^c ALK ABELLÓ   (Denmark)

Author keywords

Allergen specific T cell; Asthma; Costimulation; Cytokines

Indexed keywords

CYTOKINE; TETANUS TOXOID;

ALLERGIC ASTHMA; ARTICLE; ATOPY; CYTOKINE PRODUCTION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ALLERGENS; ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ASTHMA; CYTOKINES; DUST; HUMANS; HYPERSENSITIVITY; LYMPHOCYTE ACTIVATION; MITES; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0031867521     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.00306.x     Document Type: Article

References (51)

1. Weaver CT, Unanue ER. The costimulatory function of antigen-presenting cells. Immunol Today 1990; 11:49-55.
2. Schwartz RH. Costimulation of T lymphocytes: The role of CD28, CTLA-4 and B7/BBI in interleukin-2 production and immunotherapy. Cell 1992; 71:1065-8.
3. Jenkins MK, Johnson JG. Molecules involved in T-cell costimulation. Curr Op Immunol 1993; 5:361-7.
4. Jenkins MK. The role of cell division in the induction of clonal anergy. Immunol Today 1992; 13:69-73.
5. Gimmi CD, Freeman GJ, Gribben JG et al. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci USA 1991; 88:6575-9.
6. Hathcock KS, Laszlo G, Dickler HB, Bradshaw J, Linsley P, Hodes RJ. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Sci 1993; 262:905-7.
7. Koulova L, Clark EA, Shu G, Dupont B. The CD, 28 ligand B, 7/BB. 1 provides costimulatory signal for alloactivation of CD4+ T cells. J Exp Med 1991; 173:759-62.
8. Young JW, Koulova L, Soergel SA, Clark EA, Steinman RM, Dupont B. The B, 7/BB. 1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J Clin Invest 1992; 90:229-37.
9. Azuma M, Ito D, Yagita H et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366:76-9.
10. Freeman GJ, Gribben JG, Boussiotis VA et al. Cloning of B7-2:A CTLA-4 counter-receptor that costimulates human T cell proliferation. Sci 1993; 262:909-11.
11. Jenkins MK, Taylor PS, Norton SD, Urdahl KBCD. 28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol 1991; 147:2461-6.
12. Linsley PS, Brady W, Grosmaire L et al. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991; 173:721-30.
13. Radvanyi LG, Shi Y, Vaziri H et al. CD28 costimulation inhibits TCR-induced apopotosis during a primary T cell response. J Immunol 1996; 156:1788-98.
14. Linsley PS, Brady W, Urnes M et al. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174:561-9.
15. Linsley PS, Greene JL, Tan P et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med 1992; 176:1595-604.
16. Walunas TL, Lenschow DJ, Bakker CY et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1:405-13.
17. Sethna MP, van Parijs L, Sharpe AH, Abbas AK, Freeman GJ. A negative regulatory function of B7 revealed in B7.1 transgenic mice. Immunity 1994; 1:415-21.
18. Waterhouse P, Penninger JM, Timms E et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 (see comments). Sci 1995; 270:985-8.
19. Chen S, Ashe S, Brady WA et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992; 71:1093-102.
20. Townsend SE, Allison JP. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Sci 1993; 259:370.
21. Turka LA, Linsley PS, Lin H et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89:11102-5.
22. Lenschow DJ, Zeng Y, Thistlethwaite JR et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Sci 1992; 257:789-92.
23. Wierenga EA, Snoek M, de Groot CJ et al. Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990; 144:4651-6.
24. O'Hehir RE, Garman RD, Greenstein JL, Lamb JR. The specificity and function of T-cell responsiveness to allergens. Annu Rev Immunol 1991; 9:67-95.
25. Parronchi P, Macchia D, Piccinni M et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991; 88:4538-42.
26. Wierenga EA, Backx B, Snoek M, Koenderman L, Kapsenberg ML. Relative contribution of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia. Blood 1993; 82:1471-9.
27. Wierenga EA, Snoek M, Bos JD, Jansen HM, Kapsenberg ML. Comparison of diversity and function of house dust mite-specific T lymphocyte clones from atopic and non-atopic donors. Eur J Immunol 1990; 20:1519-26.
28. Pène J, Rousset F, Brière H et al. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons G and A and prostaglandin E2. Proc Natl Acad Sci USA 1988; 85:6880-4.
29. Snapper CM, Paul WE. Interferon and B. cell stimulatory factor-1 reciprocally regulate Ig isotype production. Sci 1987; 236:944-7.
30. Gilbert KM, Hoang KD, Weigle WO. Th1 and Th2 clones differ in their response to a tolerogenic signal. J Immunol 1990; 144:2063-71.
31. de Boer M, Kasran A, Kwekkeboom J et al. Ligation of B 7 with CD 28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur J Immunol 1993; 23:3120-5.
32. McArthur JG, Raulet DH. CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J Exp Med 1993; 178:1645-53.
33. Webb LM, Feldmann M. Critical role of CD28/B7 costimulation in the development of human Th2 cytokine-producing cells. Blood 1995; 86:3479-86.
34. Bouaboula M, Legoux P, Pessegue B et al. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J Biol Chem 1992; 267:21830-8.
35. Yi-qun Z, van Neerven RJJ, Kasran A, de Boer M, Ceuppens JL. Differential requirements for co-stimulatory signals from B7 family members by resting vs. recently activated memory T cells towards soluble recall antigens. Int Immunol 1996; 8:37-44.
36. Rattis FM, Peguet-Navarro J, Staquet MJ et al. Expression and function of B7-1 (CD80) abd B7-2 (CD86) on human epidermal Langerhans cells. Eur J Immunol 1996; 26:449-53.
37. Lanier LL, O'Fallon S, Somoza C et al. CD80 (B7) and CD86 (B70): provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995; 154:97-105.
38. Matulonis U, Dosiou C, Freeman G et al. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct. J Immunol 1996; 156:1126-31.
39. Gajewski TF. B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro. J Immunol 1996; 156:465-72.
40. Greenbaum LA, Horowitz, JB, Woods A et al. Autocrine growth of CD4+ T cells. Differential effects of IL-1 on helper and inflammatory cells. J Immunol 1988; 140:1555-60.
41. Lu P, di Zhou X, Chen SJ et al. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J Exp Med 1994; 180:693-8.
42. Kuchroo VJ, Das MP, Brown JA et al. B7-1 and B7-2 costimulalory molecules activate diferentially the Th1/Th2 development pathways: Application to autoimmune disease therapy. Cell 1995; 80:707-18.
43. Freeman GJ, Boussiotis VA, Anumanthan A et al. B7-1 and B7-2 do not deliver identical costimulatory signals since B7-2, but not B7-1 costimulates the initial production of IL-4. Immunity 1995; 2:253-61.
44. Sloan-Lancaster J, Evavold BD, Allen PM. Th2 cell clonal anergy as a consequence of partial activation. J Exp Med 1994; 180:1195-205.
45. Fasler S, Aversa G, Terr A et al. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13. J Immunol 1995; 155:4199-206.
46. Keane-Meyers A, Gause WC, Linsley PS, Chen SJ, Wills-Karp M. B7-CD, 28/CTLA 4-costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J Immunol 1997; 158:2042-9.
47. Tsuyuki S, Tsuyuki J, Einsle K, Kopf M, Coyle AJ. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med 1997; 185:1671-9.
48. Harris N, Peach R, Naemura J, Linsley PS, Legros G, Ronchese FCD. 80 costimulation is essential for the induction of airway eosinophilia. J Exp Med 1997; 185:177-82.
49. Krinzman SJ, Desanctis GT, Cernadas M et al. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J Clin Invest 1996; 98:2693-9.
50. O'Hehir RE, Busch R, Rothbard JB, Lamb JR. An in vitro model of peptide-mediated immunomodulation of the human T cell response to Dermatophagoides spp. (house dust mite). J Allergy Clin Immunol 1991; 87:1120-7.
51. O'Hehir RE, Yssel H, Verma S, de Vries JE, Spits H, Lamb JR. Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy. Int Immunol 1991; 3:819-26.